Yunqi capital, 5.1% holder and one of staar surgical company's largest shareholders, announces intention to vote against the proposed sale to alcon

Hong kong--(business wire)--yunqi capital limited (together with its affiliates and the funds it advises, “yunqi capital”), an investment management firm and 5.1% shareholder of staar surgical company (“staar”) (nasdaq:staa), today announced its opposition to the company's proposed sale to alcon inc. (six/nyse:alc) on the terms announced on august 5, 2025. yunqi capital released the following open letter to fellow staar shareholders explaining why it opposes the transaction: september 22, 2025.
ALC Ratings Summary
ALC Quant Ranking